gebhart/patrepeval huggingface dataset:
Stochastic resonance (1998)

Over the last two decades, stochastic resonance has continuously attracted considerable attention. The term is given to a phenomenon that is manifest in nonlinear systems whereby generally feeble input information (such as a weak signal) can be be amplified and optimized by the assistance of noise. The effect requires three basic ingredients: (i) an energetic activation barrier or, more generally, a form of threshold; (ii) a weak coherent input (such as a periodic signal); (iii) a source of noise that is inherent in the system, or that adds to the coherent input. Given these features, the response of the system undergoes resonance-like behavior as a function of the noise level; hence the name stochastic resonance. The underlying mechanism is fairly simple and robust. As a consequence, stochastic resonance has been observed in a large variety of systems, including bistable ring lasers, semiconductor devices, chemical reactions, and mechanoreceptor cells in the tail fan of a crayfish. In this paper, the authors report, interpret, and extend much of the current understanding of the theory and physics of stochastic resonance. They introduce the readers to the basic features of stochastic resonance and its recent history. Definitions of the characteristic quantities that are important to quantify stochastic resonance, together with the most important tools necessary to actually compute those quantities, are presented. The essence of classical stochastic resonance theory is presented, and important applications of stochastic resonance in nonlinear optics, solid state devices, and neurophysiology are described and put into context with stochastic resonance theory. More elaborate and recent developments of stochastic resonance theory are discussed, ranging from fundamental quantum properties---being important at low temperatures---over spatiotemporal aspects in spatially distributed systems, to realizations in chaotic maps. In conclusion the authors summarize the achievements and attempt to indicate the most promising areas for future research in theory and experiment.
Auto‐Antibodies to Tumour Necrosis Factor a in Healthy Humans and Patients with Inflammatory Diseases and Gram‐Negative Bacterial Infections (1989)

A semi-quantitative immunoblotting method was developed to screen for serum auto-antibodies against tumour necrosis factor alpha (TNF alpha). Forty nitrocellulose strips containing identical amounts of human recombinant TNF alpha (rTNF alpha) were prepared for each set-up, and the anti-TNF alpha antibody immunoreactivities were scored according to the density of the resulting colour reaction. A significant number of sera from apparently healthy donors contained detectable auto-antibodies to TNF alpha (40%), while the strongest reaction was observed in 8%. A higher prevalence of anti-TNF alpha antibodies was found in sera from patients with Gram-negative bacterial septicaemia (66%), cystic fibrosis with chronic Pseudomonas aeruginosa lung infection (72%), and various rheumatic diseases (61%). The antibodies in sera from these patients belonged primarily to the IgG and IgM classes, the latter exhibiting the strongest response. Longitudinally collected serum samples from patients in septic endotoxin shock revealed that the anti-TNF alpha antibodies were induced initially during septicaemia, reaching maximum reactivities within the first week and returning to low or undetectable levels on days 9-20.
Alkylating DNA damage stimulates a regulated form of necrotic cell death (2004)

Necrosis has been considered a passive form of cell death in which the cell dies as a result of a bioenergetic catastrophe imposed by external conditions. However, in response to alkylating DNA damage, cells undergo necrosis as a self-determined cell fate. This form of death does not require the central apoptotic mediators p53, Bax/Bak, or caspases and actively induces an inflammatory response. Necrosis in response to DNA damage requires activation of the DNA repair protein poly(ADP-ribose) polymerase (PARP), but PARP activation is not sufficient to determine cell fate. Cell death is determined by the effect of PARP-mediated beta-nicotinamide adenine dinucleotide (NAD) consumption on cellular metabolism. Cells using aerobic glycolysis to support their bioenergetics undergo rapid ATP depletion and death in response to PARP activation. In contrast, cells catabolizing nonglucose substrates to maintain oxidative phosphorylation are resistant to ATP depletion and death in response to PARP activation. Because most cancer cells maintain their ATP production through aerobic glycolysis, these data may explain the molecular basis by which DNA-damaging agents can selectively induce tumor cell death independent of p53 or Bcl-2 family proteins.
Dynamic itemset counting and implication rules for market basket data (1997)

We consider the problem of analyzing market-basket data and present several important contributions. First, we present a new algorithm for finding large itemsets which uses fewer passes over the data than classic algorithms, and yet uses fewer candidate itemsets than methods based on sampling. We investigate the idea of item reordering, which can improve the low-level efficiency of the algorithm. Second, we present a new way of generating “implication rules,” which are normalized based on both the antecedent and the consequent and are truly implications (not simply a measure of co-occurrence), and we show how they produce more intuitive results than other methods. Finally, we show how different characteristics of real data, as opposed by synthetic data, can dramatically affect the performance of the system and the form of the results.
Fabrication of Y-Ba-Cu-O Superconducting Films on Cu Substrates by an Electrophoretic Deposition Technique (1990)

Direct formation of Y 1 Ba 2 Cu 3 O 7- x films on Cu substrates by electrophoretic deposition is studied, Electrophoretic deposition was carried out using presintered Y 1 Ba 2 Cu 3 O 7- x powder dispersed in distilled acetone. The deposited films were annealed in air at 900°C. We succeeded in obtaining superconducting Y 1 Ba 2 Cu 3 O 7- x films on Cu substrates. The films on Cu plates and Cu film/YSZ exhibited the zero-resistance state at 66 K and 76 K, respectively. Interfacial chemical reactions at the Y 1 Ba 2 Cu 3 O 7- x /Cu interface are discussed. The achievement of the zero-resistance state is considered to be due to the reduction of the interfacial reactions.
Therapeutic efficacy of recombinant interleukin-6 (IL-6) alone and combined with recombinant human IL-3 in a nonhuman primate model of high-dose, sublethal radiation-induced marrow aplasia (1994)

Using a nonhuman-primate model of radiation-induced bone marrow aplasia, we examined whether the single, concomitant, or sequential administration of recombinant human interleukin-3 (IL-3) and IL-6 would promote bone marrow regeneration measured by an increase in circulating platelets (PLT) and neutrophils (PMN). Rhesus monkeys were irradiated at 450 cGy and were randomly assigned to one of five treatment protocols, receiving IL-6; IL-3; combined IL-6 and IL-3; sequential IL- 3 and IL-6; or human serum albumin (HSA) as a control. Cytokines or HSA were administered at total dosages of 15 micrograms/kg/day. Complete blood counts and white blood cell differentials were monitored for 60 days postirradiation. Both IL-3 and IL-6 significantly enhanced the regeneration of PLTs and decreased the duration of thrombocytopenia (P = .005) without affecting PMN recovery. The radiation-induced anemia that was observed in the HSA-treated controls was less severe and resolved more quickly in the IL-6 treated animals. Sequential IL-3/IL-6 significantly increased the production of PLTs when compared with the HSA-treated controls (P = .003) and monkeys receiving concomitant IL- 3/IL-6 (P = .041) but did not alter PMN levels significantly (P = .80). Coadministration of IL-6 and IL-3 did not enhance PLT but improved PMN recovery over IL-6 alone. In this primate model of marrow aplasia, IL-6 significantly enhanced the regeneration of PLTs but had no significant effect on PMN production, and did not exacerbate radiation-induced anemia. Furthermore, the use of sequentially administered IL-3 and IL-6 may improve PLT recovery as compared with concurrent IL-3/IL-6 administration, although this protocol is not significantly different in effect than either cytokine alone.
Replication and pathogenesis of the AIDS virus. (1988)

Some of the major features of the acquired immune deficiency syndrome may be understood in terms of the characteristics of the virus. Life-long infection is a consequence of the life cycle of retroviruses, the formation of stably integrated viral genetic information into host-cell DNA. The silent infection, controlled replication, and profile replication may be understood in terms of the interactions of the positive and negative regulatory genes that control virus growth. Selective infectivity and selective cytotoxicity of HIV-1 are primarily the consequences of the properties of the envelope glycoprotein and its interactions with the surface CD4 molecule. The ability of HIV-1 to enter a state of prolific replication in the presence of an antiviral immune response is largely attributed to the design of the outside of the virus. The functional domains of the envelope glycoprotein are not accessible to the immune system and other regions appear to be covered by a dense cloud of sugar molecules. Concealment of the virus by regulated growth, by budding to the interior surfaces of macrophages as well as concealment by a sugar coating, may help to explain the failure to protect chimpanzees from infection by candidate vaccines. Rapid medical prophylaxis is required in populations that currently experience high incidence of HIV-1 infection. Chemoprevention, the use of chemicals to prevent establishment of viral infection, in addition to vaccination should be investigated as means to control the AIDS epidemic.
Prospective Trial of Sacral Neuromodulation for Refractory Overactive Bladder Syndrome in Korean Patients (2013)

Sacral neuromodulation is an effective and safe treatment for refractory overactive bladder.
Capacity Fade Mechanisms and Side Reactions in Lithium‐Ion Batteries (1998)

The capacity of a lithium‐ion battery decreases during cycling. This capacity loss or fade occurs due to several different mechanisms which are due to or are associated with unwanted side reactions that occur in these batteries. These reactions occur during overcharge or overdischarge and cause electrolyte decomposition, passive film formation, active material dissolution, and other phenomena. These capacity loss mechanisms are not included in the present lithium‐ion battery mathematical models available in the open literature. Consequently, these models cannot be used to predict cell performance during cycling and under abuse conditions. This article presents a review of the current literature on capacity fade mechanisms and attempts to describe the information needed and the directions that may be taken to include these mechanisms in advanced lithium‐ion battery models.
Intraoperative use of dual fiberoptic catheter for simultaneous in vivo visualization and laser vaporization of peripheral atherosclerotic obstructive disease (1984)

Since laser energy has been shown to produce controlled thermal injury to atherosclerotic plaques from postmortem human hearts, a 3-mm diameter fiberoptic catheter was devised and tested for use in peripheral vessels. The catheter has channels for viewing, laser delivery, and suction/flushing. In five femoral or carotid arteries from three dogs implanted with near-total human atherosclerotic obstructions, the fiberoptic catheter was capable of viewing and targeting the atherosclerotic plaque for laser irradiation. The plaque was vaporized using 5 watts with time exposures lasting from 2 to 5 sec from an argon-ion laser. In three other animals each implanted with a 3- to 4-cm long segment of human cadaver atherosclerotic vessel, the fiberoptic catheter clearly visualized the internal diseased vascular wall. Thus, this investigation provides the initial demonstration and practicality of applying a flexible dual fiberoptic catheter for simultaneous in vivo visualization and laser vaporization of peripheral atherosclerotic disease.
ENA-78 Is an Important Angiogenic Factor in Idiopathic Pulmonary Fibrosis (2001)

Idiopathic pulmonary fibrosis (IPF) is a chronic and often fatal disorder. Fibroplasia and deposition of extracellular matrix are dependent, in part, on angiogenesis and vascular remodeling. We obtained open lung biopsies from patients undergoing thoracic surgery for reasons other than interstitial lung disease (control) (n = 78) and from patients with IPF (n = 91). We found that levels of epithelial neutrophil-activating peptide 78 (ENA-78) were greater from tissue specimens of IPF patients, as compared with control subjects. When ENA-78 was depleted from IPF tissue specimens, tissue-derived angiogenic activity was markedly reduced. Immunolocalization of ENA-78 demonstrated that hyperplastic Type II pneumocytes and macrophages were the predominant cellular sources of ENA-78. These findings support the notion that ENA-78 may be an important additional factor that regulates angiogenic activity in IPF.
Fifty years of research on the plasma kallikrein-kinin system: From protein structure and function to cell biology and in-vivo pathophysiology (2007)

Fifty years of research on the plasma kallikrein-kinin system: From protein structure and function to cell biology and in-vivo pathophysiology -
Sucrose is involved in the diazotrophic metabolism of the heterocyst‐forming cyanobacterium Anabaena sp (2002)

Sucrose synthase (SuS) expression was studied in the filamentous, nitrogen-fixing cyanobacterium Anabaena sp. PCC 7119. SuS activity, SusA polypeptide, and susA mRNA levels were lower in cells cultured diazotrophically than in the presence of combined nitrogen. An insertional susA mutant presented a dramatic increase in sucrose levels, whereas the disaccharide was not detectable in a susA overexpressing strain, indicating that SusA is involved in the cleavage of sucrose in vivo. Diazotrophic growth was impaired in the susA overexpressing strain, suggesting a role for sucrose in diazotrophic metabolism and the involvement of SusA in the control of carbon flux in the N(2)-fixing filament.
Mutant strains of Saccharomyces cerevisiae lacking sphingolipids synthesize novel inositol glycerophospholipids that mimic sphingolipid structures. (1993)

Mutant strains of Saccharomyces cerevisiae, termed SLC, make no detectable sphingolipids when cultured without a sphingolipid long chain base such as phytosphingosine (Dickson, R.C., Wells, G.B., Schmidt, A., and Lester, R.L. (1990) Mol. Cell. Biol. 10, 2176-2181). When grown with phytosphingosine they make sphingolipids in normal amounts. SLC strains carry a secondary suppressor mutation that bypasses the need to synthesize a long chain base. Hypothetically, the suppressor mutation could function by mutating a gene whose protein product required a sphingolipid for function, by increasing the level of one or more endogenous lipids, or by making new lipid(s). Here we demonstrate that SLC strains make novel inositol glycerophospholipids when cultured without a long chain base. The novel lipids are phosphatidylinositol (PI), mannosyl-PI, and inositol-P-(mannosyl-PI), containing 1 mol of C26 fatty acid, ordinarily found in yeast sphingolipids but not usually found in glycerophospholipids; the C26 fatty acid appears to be located at the SN-2 position of the glycerol. In addition, mono-fattyacyl versions of these three compounds were also identified. The polar head groups and hydrophobic portions of these novel lipids are strikingly similar to S. cerevisiae sphingolipids found in wild-type cells. We speculate that the novel lipids structurally mimic sphingolipids and thereby compensate for some sphingolipid function(s) necessary for growth.
Chlamydial vaccines. (1989)

With few exceptions, immunity from chlamydiosis availed by current vaccines is limited and can even be detrimental. Possible reasons for failure include immunotype or strain differences, ill-defined virulence variation, presentation of deleterious antigens, and incorrect presentation of critical antigens to the body. Antigens that stimulate neutralizing antibodies active at 2 steps of infection have been identified. A third step, prevention of phagolysosomal fusion, needs to be further studied, and causal antigens need to be identified. A fourth possible stage for antibody participation is in antibody-dependent cell-mediated cytotoxicity. If chlamydial antigens are expressed on the surface of infected cells, this mechanism of destruction of infected cells and the antigens that elicit it will need to be more fully examined. Cell-mediated immune responses participating in eliminating chlamydial infections need to be further clarified. Activated macrophages are the best characterized effector mechanism of cell-mediated immunity thus far, regardless of the stimulatory cytokines involved. It is important to determine how sensitized lymphocytes recognize antigen(s) that cause them to release macrophage-activating cytokines. It must be determined whether chlamydial antigens are expressed on the surface of infected cells and then recognized by potential cytokine-releasing lymphocytes in context with major histocompatibility antigens (surface expression) or whether they are recognized on antigen-presenting cells functioning in more of a scavenging capacity. Membrane expression of antigen is also important in that it also defines whether cytotoxic T cells and antibody-dependent cell-mediated cytotoxicity have roles in resistance to chlamydial infection. Also, it is important to realize the possible limitation of these mechanisms to systemic sites of the body. If membrane expression does occur, it must be determined how it functions at mucosal sites, whether it occurs at the luminal surface of mucosal epithelial cells only, or whether there is expression of antigens at abluminal membrane surfaces perhaps more accessible to such immune effector mechanisms. Delivery of critical antigens to the individual is the final component in establishing effective vaccines. Carrier systems capable of stimulating long-lasting mucosal and systemic immunity are available and need to be further studied as protective immunogens become available.
Three-dimensional registration and fusion of ultrasound and MRI using major vessels as fiducial markers (2001)

This paper describes fusion of three-dimensional (3-D) ultrasound (US) and magnetic resonance imaging (MRI) data sets, without the assistance of external fiducial markers or external position sensors. Fusion of these two modalities combines real-time 3-D ultrasound scans of soft tissue with the larger anatomical framework from MRI. The complementary information available from multiple imaging modalities warrants the development of robust fusion capabilities. We describe the data acquisition, specialized algorithms, and results for 3-D fused data from phantom studies and in vivo studies of the normal human vasculature and musculoskeletal systems.
Multi-level cell Spin Transfer Torque MRAM based on stochastic switching (2013)

Spin Transfer Torque Magnetic Random Access Memory (STT-MRAM) provides a promising pathway forthe next generation of non-volatile memory and logic chips. The perpendicular magnetic anisotropy (PMA) in CoFeB/MgO/CoFeB magnetic tunnel junction (MTJ) nanopillar provides high thermal stability and low critical current. However, the STT switching mechanism of MTJ has been revealed intrinsically stochastic, which results from the unavoidable thermal fluctuations of magnetization. This phenomenon affects deeply the reliability of hybrid CMOS/MTJ interface circuits and drives important power overhead. In this paper, we present a multilevel cell (MLC) STT-MRAM benefiting from the stochastic behaviors. It allows not only higher storage density, but also reduces the programming power and delay. This new cell can be also used as electrical synapse to build up neuromorphic computing systems or other biological networks. Monte-Carlo statistical simulations based on a 40 nm technology node have been carried out to validate its functionality and demonstrate its performance.
Coagulase-Negative Staphylococcal Bacteremia Among Very Low Birth Weight Infants: Relation to Admission Illness Severity, Resource Use, and Outcome (1995)

Nosocomial coagulase-negative bacteremia is an important complication among very low birth weight infants. Assessment of illness severity with SNAP provides information regarding nosocomial infection risk beyond that available from birth weight alone.
Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer (2012)

T790M may not be a rare event before or after TKI therapy in patients with NSCLC with EGFR-activating mutations. The pretreatment T790M mutation was associated with shorter PFS with EGFR TKI therapy in patients with NSCLC.
Defective Lymphotoxin-β Receptor-Induced NF-κB Transcriptional Activity in NIK-Deficient Mice (2001)

The role of NF-kappaB-inducing kinase (NIK) in cytokine signaling remains controversial. To identify the physiologic functions of NIK, we disrupted the NIK locus by gene targeting. Although NIK-/- mice displayed abnormalities in both lymphoid tissue development and antibody responses, NIK-/- cells manifested normal NF-kappaB DNA binding activity when treated with a variety of cytokines, including tumor necrosis factor (TNF), interleukin-1 (IL-1), and lymphotoxin-beta (LTbeta). However, NIK was selectively required for gene transcription induced through ligation of LTbeta receptor but not TNF receptors. These results reveal that NIK regulates the transcriptional activity of NF-kappaB in a receptor-restricted manner.
The Chemistry of a Novel 5,5-Diphenylhydantoin Pro-drug (1975)

Phenytoin or 5,5-diphenylhydantoin (DPH), a widely used anticonvulsant agent used primarily in the treatment of grand mal seizures, has shown erratic absorption and dissolution patterns as well as possible precipitation in the body after intravenous (I.V.) infusions of highly alkaline solutions of its sodium salt (1-6). It was the objective of this work to find a water soluble pro-drug (7,8) form of DPH which would revert to DPH in the body. The aim was to improve both the parenteral and oral bioavailability of DPH. A number of hydantoins including DPH, mephenytoin or 5-ethyl-3-methyl-5-phenylhydantoin (I), and nitrofurantoin or 1-(5-nitro-2-furfurylindene) aminohydantoin (II) are widely used as drugs. Their uses, however, have been hampered by their low water solubility combined with their weakly acidic nature. Orally the bioavailability of DPH from capsules has been erratic (1-3). The PKa of DPH, approximately 8.3 (1,9), allows DPH to be formulated as its mono-sodium salt. Formulations
The non-orthogonal fixed beam arrangement for the second proton therapy facility at the National Accelerator Center (1999)

The medical user group at the National Accelerator Center (NAC) is currently unable to treat all eligible patients with high energy protons. Developing a second proton treatment room is desirable since the 200 MeV proton beam from the NAC separated sector cyclotron is currently under-utilized during proton therapy sessions. During the patient positioning phase in one treatment room, the beam could be used for therapy in a second room. The second proton therapy treatment room at the NAC will be equipped with two non-orthogonal beam lines, one horizontal and one at 30 degrees to the vertical. The two beams will have a common isocentre. This beam arrangement together with a versatile patient positioning system (commercial robot arm) will provide the radiation oncologist with a diversity of possible beam arrangements and offers a reasonable cost-effective alternative to an isocentric gantry.